TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7594922

Group type: EXPERIMENTAL
Intervention: Multidrug therapy regimen including rifampin, isoniazid, clofazimine, and dapsone for the first 3 months followed by clofazimine and dapsone until 84 months.
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Dapsone alone for 60-80 months.
Number of subjects: 2
Study: 2301439

Group type: EXPERIMENTAL
Intervention: Vinyl glove use by hospital personnel for all body substance contact during the intervention period.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vinyl glove use (intervention wards)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control wards (no intervention)
Number of subjects: 0
Study: 7395586

Group type: EXPERIMENTAL
Intervention: Assertiveness training (twice a week for one hour for 10 weeks)
Number of subjects: 85
Study: 30604381

Group type: EXPERIMENTAL
Intervention: GM1 acupoint injection (group A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Subcutaneous injection (group B)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Healthy control group (group D)
Number of subjects: 90
Study: 27998971

Group type: EXPERIMENTAL
Intervention: S-288310 at 1 mg
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: S-288310 at 2 mg
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: S-288310
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: S-288310 with CTL induction to both peptides
Number of subjects: 38
Study: 27050101

Group type: EXPERIMENTAL
Intervention: Personalised decision aid with choice over the inclusion of up to 10 attributes
Number of subjects: 1970

Group type: COMPARATOR
Intervention: Standard decision aid with a fixed set of five attributes
Number of subjects: 1970

Group type: EXPERIMENTAL
Intervention: Personalised decision aid
Number of subjects: 1970

Group type: COMPARATOR
Intervention: Standard decision aid
Number of subjects: 1970
Study: 25090414

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG), 10% Purified (Gamunex) administered monthly.
Number of subjects: 11

Group type: COMPARATOR
Intervention: 0.1% albumin solution (placebo) administered monthly.
Number of subjects: 11
Study: 22696005

Group type: EXPERIMENTAL
Intervention: Early postoperative liver volume regeneration index (RI(early)) at 7 days after surgery
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Total liver volume regeneration index (RI(total)) at 6 months after surgery
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Liver remnant (LR) volume as a percentage of TLV at 7 days after surgery
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Liver remnant (LR) volume as a percentage of TLV at 6 months after surgery
Number of subjects: 91
Study: 18820883

Group type: EXPERIMENTAL
Intervention: Duodenum-preserving pancreatic head resection (DPPHR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pancreatoduodenectomy (PD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DPPHR techniques (Beger, Frey, Berne modifications)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Berne modification of DPPHR
Number of subjects: 0
Study: 17240130

Group type: EXPERIMENTAL
Intervention: Wormwood (3 x 500 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 15665022

Group type: EXPERIMENTAL
Intervention: Metformin 500 mg three times daily for 6 months
Number of subjects: 60
Study: 12468310

Group type: EXPERIMENTAL
Intervention: Lamb and rice diet
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Chicken and rice diet
Number of subjects: 20
Study: 9658743

Group type: COMPARATOR
Intervention: Oral zinc tolerance test
Number of subjects: 382

Group type: COMPARATOR
Intervention: Oral zinc dipicolinate tolerance test
Number of subjects: 382

Group type: COMPARATOR
Intervention: Serum zinc concentration
Number of subjects: 382

Group type: COMPARATOR
Intervention: Fecal chymotrypsin activity
Number of subjects: 382
Study: 7660424

Group type: EXPERIMENTAL
Intervention: Lambdacyhalothrin-treated bed nets
Number of subjects: 5

Group type: COMPARATOR
Intervention: Untreated nets
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Treated nets
Number of subjects: 5
Study: 2666046

Group type: EXPERIMENTAL
Intervention: Intermittent Mandatory Ventilation (IMV)
Number of subjects: 200

Group type: COMPARATOR
Intervention: T-piece
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both IMV and T-piece
Number of subjects: 200
Study: 30898388

Group type: EXPERIMENTAL
Intervention: Intravenous Acetaminophen (IA) 1000 mg every 6 hours
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (standard pain control)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Intravenous Acetaminophen (IA)
Number of subjects: 97
Study: 29145879

Group type: EXPERIMENTAL
Intervention: 2×10^6 per kilogram human umbilical-cord-derived MSCs (UC-MSCs) via peripheral vein injection preoperatively, and 5×10^6 cells via renal arterial injection during surgery, with standard induction therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard induction therapy
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: UC-MSCs
Number of subjects: 100
Study: 24995962

Group type: EXPERIMENTAL
Intervention: Ultrathin flexible colonoscope (PCF‐PQ260)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Conventional colonoscope (PCF‐Q260A)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 84
Study: 24521323

Group type: EXPERIMENTAL
Intervention: Neurobiology-based psychoeducation intervention (30-min lecture)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 132
Study: 21518701

Group type: EXPERIMENTAL
Intervention: Leuprorelin therapy
Number of subjects: 1

Group type: COMPARATOR
Intervention: Healthy control
Number of subjects: 1
Study: 20035579

Group type: EXPERIMENTAL
Intervention: Risperidone 1-3 mg/day
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Risperidone 4-6 mg/day
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 17696822

Group type: EXPERIMENTAL
Intervention: Ipilimumab (Medarex/Bristol‐Myers Squibb)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CP‐675,206 (Pfizer/Abgenix, now Amgen)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 15361496

Group type: EXPERIMENTAL
Intervention: Slow ramp rectal distension (40 ml/min)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Rapid phasic rectal distension (900 ml/min, 10, 20, 30, and 40 mm Hg)
Number of subjects: 14
Study: 11685356

Group type: EXPERIMENTAL
Intervention: Patellar tendon autograft (PT)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Hamstring tendon autograft (HS)
Number of subjects: 65
Study: 9725691

Group type: EXPERIMENTAL
Intervention: Vancomycin administration during surgery
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control day (no surgery)
Number of subjects: 9
Study: 7991971

Group type: EXPERIMENTAL
Intervention: Biofeedback without electronic equipment
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (21 normal subjects)
Number of subjects: 47
Study: 2728887

Group type: EXPERIMENTAL
Intervention: Bone cement (methylmethacrylate) at operation
Number of subjects: 2

Group type: COMPARATOR
Intervention: Plaster cast immobilization
Number of subjects: 2
Study: 4804130

Group type: EXPERIMENTAL
Intervention: Mothers' class educational program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 31277966

Group type: EXPERIMENTAL
Intervention: Bremelanotide 1.75 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27655324

Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen
Number of subjects: 353

Group type: COMPARATOR
Intervention: Standard oxygen
Number of subjects: 353
Study: 26067628

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided pulsed radiofrequency (PRF) treatment and night splint
Number of subjects: 44

Group type: COMPARATOR
Intervention: Night splint alone
Number of subjects: 44
Study: 23541163

Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Stress Reduction (MBSR)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Stress Management Education (SME)
Number of subjects: 93
Study: 21806766

Group type: EXPERIMENTAL
Intervention: Physician and patient education (PPE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patient education only (PAE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physician education only (PHE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 0
Study: 18508277

Group type: EXPERIMENTAL
Intervention: Endoscopic saphenous vein harvesting (EVH)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Open venous harvesting (OVH)
Number of subjects: 132
Study: 16101670

Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Zone diet
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Zone diet with Omega-3
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control diet (placebo)
Number of subjects: 33
Study: 12074361

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (n = 22), treadmill exercise program, 3 times per week for 12 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (n = 20), no exercise
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (n = 22)
Number of subjects: 42
Study: 10434217

Group type: EXPERIMENTAL
Intervention: Lightwand intubation (Trachlight, n = 25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Direct-vision laryngoscopy (Laryngoscopy, n = 25)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 7582395

Group type: EXPERIMENTAL
Intervention: Inhaled B-agonist
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New quality of life measuring instrument
Number of subjects: 0
Study: 2350094

Group type: EXPERIMENTAL
Intervention: Codeine (90 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32573

Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31673875

Group type: EXPERIMENTAL
Intervention: Fluconazole 400 mg/day orally on days 1-11, single oral dose of erdafitinib 4 mg on day 5
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg/day orally on days 1-11, single oral dose of erdafitinib 4 mg on day 5
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single oral dose of erdafitinib 4 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Coadministration of erdafitinib with itraconazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Coadministration of erdafitinib with fluconazole or itraconazole
Number of subjects: 0
Study: 29293386

Group type: COMPARATOR
Intervention: Intensity-Modulated Radiotherapy (IMRT)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Passive Scattering Proton Therapy (PSPT)
Number of subjects: 149
Study: 27437826

Group type: EXPERIMENTAL
Intervention: PC-1005 (MIV-150 and zinc acetate in a carrageenan gel)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 23982436

Group type: EXPERIMENTAL
Intervention: Nurse-led care (NLC)
Number of subjects: 181
Study: 22418831

Group type: EXPERIMENTAL
Intervention: Itraconazole (200 mg daily for 5 days)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 15
Study: 21112423

Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise (AE)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Combined exercise (CE)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Usual-care control
Number of subjects: 64
Study: 18178780

Group type: EXPERIMENTAL
Intervention: Cinacalcet-based regimen
Number of subjects: 552

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 552
Study: 15968009

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) - 0.625 mg of conjugated estrogen daily, plus 5 mg of medroxyprogesterone for 12 days per month
Number of subjects: 351

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351
Study: 14529932

Group type: EXPERIMENTAL
Intervention: Ketoconazole (200 mg daily)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (no ketoconazole)
Number of subjects: 64
Study: 11127126

Group type: EXPERIMENTAL
Intervention: Magnification (3x to 7.5x) with adequate contrast reserve
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low contrast reserve
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Magnification higher than required for letter recognition (increased acuity reserve)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High contrast reserve with magnifications of 5x and higher
Number of subjects: 0
Study: 9336154

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 290
Study: 1283553

Group type: EXPERIMENTAL
Intervention: Postoperative pain experience as measured by the McGill Pain Questionnaire
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Deeper somatic pain descriptors (e.g., throbbing, stabbing, cramping, pulling, burning)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Superficial pain descriptors (e.g., pricking, sharp, pinching, itching, sore, tender)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Comparison of findings with Taenzer's study in Canada
Number of subjects: 246
Study: 2864048

Group type: EXPERIMENTAL
Intervention: Lofentanil 5 micrograms
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.3 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Physiological saline
Number of subjects: 60
Study: 28375777

Group type: EXPERIMENTAL
Intervention: Resistance training (RT) for 24 weeks
Number of subjects: 32
Study: 26296097

Group type: EXPERIMENTAL
Intervention: Highly engaging conditions (game group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Mechanically identical but less engaging conditions (sterile group)
Number of subjects: 40
Study: 24117531

Group type: EXPERIMENTAL
Intervention: Low-fat meal
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: High-fat meal
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg (single dose)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg (multiple doses)
Number of subjects: 29
Study: 22332528

Group type: EXPERIMENTAL
Intervention: Acutrak full thread headless hollow compression screw (surgical group)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Conservative treatment (control group)
Number of subjects: 31
Study: 19738394

Group type: EXPERIMENTAL
Intervention: Viscocanalostomy
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Deep sclerectomy
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Deep sclerectomy plus mitomycin C (MMC)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Trabeculectomy
Number of subjects: 17

Group type: COMPARATOR
Intervention: Trabeculectomy plus MMC
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Viscocanalostomy and Deep Sclerectomy
Number of subjects: 17
Study: 17509338

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 15958837

Group type: EXPERIMENTAL
Intervention: Indinavir/Ritonavir 800/200 mg twice daily
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Indinavir/Ritonavir 400/400 mg twice daily
Number of subjects: 44
Study: 11796432

Group type: EXPERIMENTAL
Intervention: Tobramycin solution for inhalation (TSI) 300 mg
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 10232690

Group type: EXPERIMENTAL
Intervention: big ET‐1 infusion (0.2, 1, and 4 pmol/kg per min for 20 min)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: big ET‐1 infusion
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: ET‐1 infusion
Number of subjects: 53

Group type: COMPARATOR
Intervention: HD procedure
Number of subjects: 53

Group type: COMPARATOR
Intervention: HD patients with ischemic heart disease
Number of subjects: 53
Study: 8907097

Group type: EXPERIMENTAL
Intervention: Live-contact weight loss group (videotaped)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Live-contact weight loss group (not videotaped)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Television-delivered group (observed videotaped sessions)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Television-delivered group
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Live-contact group
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Videotaped group
Number of subjects: 71
Study: 1297921

Group type: EXPERIMENTAL
Intervention: Wallaby Phototherapy System (24 hours of light exposure)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (any treatment for hyperbilirubinemia)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Wallaby Phototherapy System
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46
Study: 6382639

Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate
Number of subjects: 0
Study: 31657794

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIE)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Sprint Interval Exercise (SIE)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Repeated Sprint Exercise (RSE)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Exercise (MCE)
Number of subjects: 47
Study: 29389245

Group type: EXPERIMENTAL
Intervention: 1.5 g daily ARA for 4 weeks
Number of subjects: 19
Study: 26540652

Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard conservative therapy
Number of subjects: 70
Study: 23583250

Group type: EXPERIMENTAL
Intervention: hs‐TnI assay with TIMI risk score = 0
Number of subjects: 2544

Group type: EXPERIMENTAL
Intervention: hs‐TnI assay with TIMI risk score ≤ 1
Number of subjects: 2544

Group type: EXPERIMENTAL
Intervention: TIMI risk score = 0 in the primary cohort
Number of subjects: 2544

Group type: EXPERIMENTAL
Intervention: TIMI risk score ≤ 1 in the primary cohort
Number of subjects: 2544

Group type: EXPERIMENTAL
Intervention: TIMI risk score ≤ 1 in the secondary cohort
Number of subjects: 2544
Study: 21650060

Group type: EXPERIMENTAL
Intervention: Uvulopalatopharyngoplasty with partial resection of the musculus uvulae and preservation of uvulae mucosa
Number of subjects: 36

Group type: COMPARATOR
Intervention: Uvulopalatopharyngoplasty with uvulae preservation
Number of subjects: 36
Study: 19704275

Group type: EXPERIMENTAL
Intervention: Brace therapy for compression fractures
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Physical therapy and postural instructions for compression fractures
Number of subjects: 133

Group type: COMPARATOR
Intervention: Brace or Plaster of Paris cast for burst fractures
Number of subjects: 133

Group type: COMPARATOR
Intervention: Plaster of Paris cast for burst fractures
Number of subjects: 133
Study: 16926249

Group type: EXPERIMENTAL
Intervention: Pegvisomant (doses 10-60 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pegvisomant
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study: 15019652

Group type: EXPERIMENTAL
Intervention: RCTs with 'soft' endpoints using surrogate outcomes (72, 61%)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: RCTs with numerical outcomes (102, 86%)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: RCTs with deficiencies in trial quality (12 or more dimensions deficient in half of the studies)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: RCTs lacking blinding and variations in surgical technique
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Comparative analysis of large case series and databases
Number of subjects: 119
Study: 11385196

Group type: EXPERIMENTAL
Intervention: Xylitol group (mothers chewed xylitol-sweetened gum for 21 months starting 3 months after delivery)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Fluoride group (mothers received fluoride varnish treatments at 6, 12, and 18 months after delivery)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Chlorhexidine group (mothers received chlorhexidine varnish treatments at 6, 12, and 18 months after delivery)
Number of subjects: 195
Study: 9434916

Group type: COMPARATOR
Intervention: Inspiratory Pressure Support (IPS)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Inspiratory Automatic Tube Compensation (ATC-in)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Inspiratory and Expiratory Automatic Tube Compensation (ATC-in-ex)
Number of subjects: 10

Group type: COMPARATOR
Intervention: IPS
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: ATC
Number of subjects: 10
Study: 8506477

Group type: EXPERIMENTAL
Intervention: Ofloxacin (400 mg twice daily for 10 days)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Cefoxitin (2 g intramuscularly) followed by doxycycline (100 mg twice daily orally for 10 days)
Number of subjects: 268
Study: 3693872

Group type: EXPERIMENTAL
Intervention: Vinpocetine 40 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Flunitrazepam
Number of subjects: 8
Study: 29956396

Group type: EXPERIMENTAL
Intervention: Reflexology delivered by caregivers
Number of subjects: 256

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 256
Study: 27523947

Group type: EXPERIMENTAL
Intervention: Imidacloprid 10% and moxidectin 2.5% spot on (G1)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Milbemycin oxime/praziquantel tablets (G3)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Untreated control (G2)
Number of subjects: 47
Study: 24871654

Group type: EXPERIMENTAL
Intervention: High-dose Ginseol K‐g1 (300 mg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Low-dose Ginseol K‐g1 (100 mg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 90
Study: 22545932

Group type: EXPERIMENTAL
Intervention: Consultation training of nurses (3-day residential training course on Stages of Change model, Motivational Interviewing, and guidelines for cardiovascular prevention)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Consultation training of nurses
Number of subjects: 212
Study: 21186645

Group type: EXPERIMENTAL
Intervention: Cycloferon liniment in combined therapy
Number of subjects: 40